Granules India rises on getting tentative approval from USFDA for Guaifenesin ER Tablets

13 Feb 2020 Evaluate

Granules India is currently trading at Rs. 162.45, up by 3.10 points or 1.95% from its previous closing of Rs. 159.35 on the BSE.

The scrip opened at Rs. 160.00 and has touched a high and low of Rs. 163.45 and Rs. 157.50 respectively. So far 73485 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 167.35 on 07-Feb-2020 and a 52 week low of Rs. 84.25 on 26-Jul-2019.

Last one week high and low of the scrip stood at Rs. 167.35 and Rs. 157.50 respectively. The current market cap of the company is Rs. 4144.24 crore.

The promoters holding in the company stood at 42.90%, while Institutions and Non-Institutions held 20.95% and 36.14% respectively.

Granules India has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Guaifenesin Extended-Release (ER) Tablets, 600 mg and 1200 mg (OTC), generic equivalent of Mucinex Extended-Release Tablets, 600 mg and 1200 mg, of RB Health (US) LLC. Guaifenesin ER Tablets helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive.

Granules now has a total of 23 ANDA approvals from US FDA (21 Final approvals and 2 tentative approvals).

Granules India is manufacturer and supplier of pharmaceutical products. Its products include active pharmaceutical ingredients (API) like tablets, caplets, rapid release, pharmaceutical, formulation intermediates (PFI) and Finished Dosages (FDs).

Granules India Share Price

560.65 -5.90 (-1.04%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×